HAOHAI BIOTEC(06826)

28.400+1.650+6.17%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

Company Profile
Company Name
HAOHAI BIOTEC
Market
SEHK
Establishment Date
- -
Employees
- -
Office Location
- -
Website
http://www.3healthcare.com/
Zip Code
- -
Phone
- -
Fax
- -
Introduction
Shanghai Haohai Biological Technology Co., Ltd. is a China-based company principally engaged in biological technology-related businesses. The businesses of the Company include the manufacture and sales of biological and medical hyaluronate, the research and development of biological engineering and pharmaceutical products and the provision of related services. Its products include orthopedics products, medical aesthetics and wound care products, ophthalmology products and anti-adhesion and hemostasis products, among others. Orthopedics products include sodium hyaluronate injection, medical chitosan and medical sodium hyaluronate gel. Medical aesthetics and wound care products include recombinant human epidermal growth factor (rhEGF), among others. Ophthalmology products include ophthalmic viscoelastic devices and lubricant eye drops. Anti-adhesion and hemostasis products include medical collagen sponges, among others. The Company mainly operates businesses in Mainland China.

1D
5D
Day
Week
Month

Loading ...

High

28.400

Open

27.200

Volume%

2.67

Low

26.900

Close

26.750

T/O Rate

2.00%

抱歉，当前请求异常(-1)

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"pagemeta":{"title":"HAOHAI BIOTEC(06826),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest HAOHAI BIOTEC(06826) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"HAOHAI BIOTEC,06826,HAOHAI BIOTEC股票,HAOHAI BIOTEC股票老虎,HAOHAI BIOTEC股票老虎国际,HAOHAI BIOTEC行情,HAOHAI BIOTEC股票行情,HAOHAI BIOTEC股价,HAOHAI BIOTEC股市,HAOHAI BIOTEC股票价格,HAOHAI BIOTEC股票交易,HAOHAI BIOTEC股票购买,HAOHAI BIOTEC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"HAOHAI BIOTEC(06826),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest HAOHAI BIOTEC(06826) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}},"tab":"community","symbol":"06826","data":{"stockData":{"symbol":"06826","market":"HK","secType":"STK","nameCN":"HAOHAI BIOTEC","latestPrice":28.4,"timestamp":1741939710018,"preClose":26.75,"halted":0,"volume":782860,"delay":0,"floatShares":39141800,"shares":233000000,"eps":1.9370254320968456,"marketStatus":"Market Closed","change":1.65,"latestTime":"03-14 16:08:30","open":27.2,"high":28.4,"low":26.9,"amount":21767836,"amplitude":0.056075,"askPrice":28.4,"askSize":27100,"bidPrice":28.35,"bidSize":1300,"shortable":3,"etf":0,"ttmEps":1.9370254320968456,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1742175000000},"marketStatusCode":7,"adr":0,"listingDate":1430323200000,"exchange":"SEHK","adjPreClose":26.75,"dividendRate":0.041889,"openAndCloseTimeList":[[1741915800000,1741924800000],[1741928400000,1741939200000]],"volumeRatio":2.672752846710551,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688366","market":"SH","secType":"STK","nameCN":"Shanghai Haohai Biological Technology Co.,Ltd.","latestPrice":62.34,"timestamp":1741935600000,"preClose":60.95,"halted":0,"volume":1214100,"delay":0,"premium":"-57.67"}},"tweetData":{"bottom":false,"list":[{"cardType":"TWEET","cardId":"TWEET.9023269762","cardData":[{"tweetId":"9023269762","author":{"authorId":"4103332230805300","idStr":"4103332230805300","name":"Smartkarma","avatar":"https://community-static.tradeup.com/news/39fffba2ff205c2730b5bf07e3de6647","userType":5,"introduction":"https://on.skr.ma/free4tiger","crmLevel":0,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1851,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"Shanghai Haohai Biological Technology (688366CH)- Diversified Business Layout Doesn't Secure Outlook","digest":"Haohai builds diversified business via M&amp;A,but none is growth point with high certainty. Its medical aesthetics has no obvious advantage and the valuation would be lower&nbsp;due to centralized procurement Haohai's development is fuelled by a series of acquisitions, which help Haohai establish the existing diversified businesses, but we haven’t seen any growth point with high certainty. Compared with Bloomage and Imeik, Haohai has no competitive advantage in the field of medical aesthetics. It’s also difficult for Haohai to make a substantial breakthrough without obvious product advantages. Although Haohai’s PE/TTM is significantly lower than its peers, due to centralized procurement, Haohai’s valuation could be further lower. Considering the risks, we choose to stay cautious on Haohai","plainDigest":"Haohai builds diversified business via M&A,but none is growth point with high certainty. Its medical aesthetics has no obvious advantage and the valuation would be lower due to centralized procurement Haohai's development is fuelled by a series of acquisitions, which help Haohai establish the existing diversified businesses, but we haven’t seen any growth point with high certainty. Compared with Bloomage and Imeik, Haohai has no competitive advantage in the field of medical aesthetics. It’s also difficult for Haohai to make a substantial breakthrough without obvious product advantages. Although Haohai’s PE/TTM is significantly lower than its peers, due to centralized procurement, Haohai’s valuation could be further lower. Considering the risks, we choose to stay cautious on Haohai","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1652921285000,"gmtModify":1676535189306,"symbols":["836892","836077","836263","836260","06826","836239","836149","836720","836433","836675","836826"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":1,"viewCount":505,"likeCount":23,"liked":false,"collected":false,"commentCount":16,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":true,"shareLink":"https://ttm.financial/post/9023269762","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":928,"displayRows":4,"strategy":"timeline","authorId":"4103332230805300"}]}],"size":1,"extra":{"requestId":"852eb916e78640c5b800fe13704bd537"}},"newsData":null,"noticeData":{"listData":[],"currentPage":1,"bottom":true},"companyData":{"profile":{"websiteUrl":"http://www.3healthcare.com/","stockEarnings":[{"period":"1week","weight":0.0538},{"period":"1month","weight":0.1225},{"period":"3month","weight":-0.0035},{"period":"6month","weight":-0.0553},{"period":"1year","weight":0.0039},{"period":"ytd","weight":0.0657}],"compareEarnings":[{"period":"1week","weight":-0.0112},{"period":"1month","weight":0.0962},{"period":"3month","weight":0.1997},{"period":"6month","weight":0.3795},{"period":"1year","weight":0.4126},{"period":"ytd","weight":0.1944}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Shanghai Haohai Biological Technology Co., Ltd. is a China-based company principally engaged in biological technology-related businesses. The businesses of the Company include the manufacture and sales of biological and medical hyaluronate, the research and development of biological engineering and pharmaceutical products and the provision of related services. Its products include orthopedics products, medical aesthetics and wound care products, ophthalmology products and anti-adhesion and hemostasis products, among others. Orthopedics products include sodium hyaluronate injection, medical chitosan and medical sodium hyaluronate gel. Medical aesthetics and wound care products include recombinant human epidermal growth factor (rhEGF), among others. Ophthalmology products include ophthalmic viscoelastic devices and lubricant eye drops. Anti-adhesion and hemostasis products include medical collagen sponges, among others. The Company mainly operates businesses in Mainland China.","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":-0.003935},{"month":2,"riseRate":0.4,"avgChangeRate":0.022019},{"month":3,"riseRate":0.6,"avgChangeRate":0.003435},{"month":4,"riseRate":0.888889,"avgChangeRate":0.086267},{"month":5,"riseRate":0.4,"avgChangeRate":-0.016495},{"month":6,"riseRate":0.3,"avgChangeRate":-0.007024},{"month":7,"riseRate":0.5,"avgChangeRate":0.049916},{"month":8,"riseRate":0.4,"avgChangeRate":-0.023779},{"month":9,"riseRate":0.4,"avgChangeRate":-0.017152},{"month":10,"riseRate":0.3,"avgChangeRate":-0.034187},{"month":11,"riseRate":0.5,"avgChangeRate":-0.01203},{"month":12,"riseRate":0.6,"avgChangeRate":0.037152}],"exchange":"SEHK","name":"HAOHAI BIOTEC","nameEN":"HAOHAI BIOTEC"},"aProfile":null}}}